Although the prognostic signatures based on KLFs expression have been investigated in several studies, we found that both KLF2 and KLF15 can be used as prognostic predictors independent on other KLFs in patients with breast cancer [21, 22]. This evidence concerns the gene KLF2 and breast cancer.